Platz Co.,Ltd. (7813) Stock Price

Platz's main business is the planning, development, design, manufacturing, and sales of electric beds for medical and long-term care use, as well as the processing and sales of urethane foam mattresses. The company designs and sells bed units and related equipment domestically, and also distributes products overseas, including in China, through its subsidiaries and affiliated companies.

The company serves diverse customers including welfare equipment rental businesses for home care, rental wholesalers, medical device and facility equipment sales companies for medical and senior care facilities, as well as furniture stores and mail-order retailers. Platz structures its revenue differently by sales channel: in the welfare equipment distribution market, it generates significant revenue through insurance-related transactions via rental bed sales, while in the facility market, it secures sales through bulk facility installations and sales company partnerships.

The business consists of three main divisions: medical and long-term care electric beds, urethane mattresses, and overseas sales. For home care, the company offers products including "Yokaro," "Miolet III," "Miolet III Next," and the bed grip "Knee Palo Plus." For medical and senior care facilities, it provides the "P300/P302/P301 Series," "Ardel," and "Reist," among others. The company has established a stable supply system through processing by subsidiaries and manufacturing partnerships in China.

The company aims to achieve stable growth and improved capital efficiency by expanding its domestic business foundation and diversifying revenue sources over the medium term. Building on its existing strengths—top market share in home care beds and the number two position in medical and senior care facility beds—the company plans to increase the revenue ratio from non-bed products through expanded bed-related offerings such as mattresses and new product and service launches. The company prioritizes return on equity (ROE) as a key performance metric and is working to achieve medium-term targets while balancing business investment with profitability.

Priority investment areas are concentrated in manufacturing capability, research and development, and human resource development. The company differentiates itself through "high quality, high functionality, and low cost," and manages production through quality inspection in partnership with SHENGBANG METAL, an affiliate accounted for using the equity method, which handles steel component manufacturing and assembly. To mitigate risks from rising raw material costs and currency fluctuations, the company is reviewing its production base currently concentrated in Vietnam and developing new manufacturing locations. It is also investing in R&D and strengthening product development procurement functions to enhance product competitiveness. Additionally, the company is focusing on securing and developing talent through personnel evaluation system reforms and enhanced training programs.

For new market development, the company is focusing on the medical and senior care facility market domestically and expanding new categories such as sleep-related products. For mattress development, it is expanding product lineups in partnership with Yamato Sangyo, a consolidated subsidiary, and strengthening sales operations to capture bulk installation demand from facilities. Internationally, the company is prioritizing East Asia and Southeast Asia, expanding sales in China through Fuyoruci (Shanghai) Trading Co., Ltd. and accelerating local expansion through a joint venture with the Haier Group, while also planning to strengthen distributor networks and sales infrastructure through partnerships with Korean partners.

Regarding technological innovation, the company is developing services aimed at improving product functionality and reducing burdens on care workers. Over the medium to long term, the company plans to provide solutions that "address labor shortages" through sensor improvements, enhanced operability, and mechanisms that reduce care staff workload, with continued R&D investment and advancement of production technology. Quality management is overseen and controlled by the company's internal quality department, and the company is improving supply stability and product reliability alongside diversification of manufacturing locations.